All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YC0370 | Anti-DDB2 (1F11) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 1F11 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0371 | Anti-DDB2 (2246C4a) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2246C4a | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0372 | Anti-DDB2 (8C100) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 8C100 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0373 | Anti-DDB2 (11C1023) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 11C1023 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0374 | Anti-DDB2 (D4C4) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | D4C4 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC0375 | Anti-DDB2 (CBYCD-202) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | CBYCD-202 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1270 | Anti-DDB2 (1F11) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 1F11 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1271 | Anti-DDB2 (2246C4a) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2246C4a | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1272 | Anti-DDB2 (8C100) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 8C100 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1273 | Anti-DDB2 (11C1023) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 11C1023 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1274 | Anti-DDB2 (D4C4) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | D4C4 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YC1275 | Anti-DDB2 (CBYCD-202) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYCD-202 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION